rs199915459

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_000051.4(ATM):​c.7740A>C​(p.Arg2580Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000083 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2580K) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00030 ( 0 hom., cov: 32)
Exomes š‘“: 0.000061 ( 0 hom. )

Consequence

ATM
NM_000051.4 missense

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:9B:7

Conservation

PhyloP100: 0.807

Publications

8 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.026328593).
BP6
Variant 11-108331989-A-C is Benign according to our data. Variant chr11-108331989-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 127448.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.7740A>Cp.Arg2580Ser
missense
Exon 52 of 63NP_000042.3
ATM
NM_001351834.2
c.7740A>Cp.Arg2580Ser
missense
Exon 53 of 64NP_001338763.1Q13315
C11orf65
NM_001330368.2
c.641-22918T>G
intron
N/ANP_001317297.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.7740A>Cp.Arg2580Ser
missense
Exon 52 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.7740A>Cp.Arg2580Ser
missense
Exon 53 of 64ENSP00000388058.2Q13315
C11orf65
ENST00000615746.4
TSL:1
c.*1270-422T>G
intron
N/AENSP00000483537.1Q8NCR3-1

Frequencies

GnomAD3 genomes
AF:
0.000296
AC:
45
AN:
152224
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.0000637
AC:
16
AN:
251122
AF XY:
0.0000737
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000441
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.0000609
AC:
89
AN:
1461756
Hom.:
0
Cov.:
31
AF XY:
0.0000605
AC XY:
44
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33480
American (AMR)
AF:
0.000514
AC:
23
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39662
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000378
AC:
42
AN:
1111944
Other (OTH)
AF:
0.000298
AC:
18
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000295
AC:
45
AN:
152342
Hom.:
0
Cov.:
32
AF XY:
0.000295
AC XY:
22
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41578
American (AMR)
AF:
0.00203
AC:
31
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68038
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000178
Hom.:
0
Bravo
AF:
0.000801
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
2
Hereditary cancer-predisposing syndrome (5)
-
4
1
not provided (5)
-
1
1
Ataxia-telangiectasia syndrome (2)
-
-
1
ATM-related disorder (1)
-
-
1
Familial cancer of breast (1)
-
1
-
not specified (1)
-
-
1
Ovarian cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
18
DANN
Benign
0.86
DEOGEN2
Benign
0.051
T
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.50
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.68
T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.026
T
MetaSVM
Benign
-0.71
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
0.81
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.98
N
REVEL
Uncertain
0.36
Sift
Benign
0.13
T
Sift4G
Benign
0.84
T
Polyphen
0.0010
B
Vest4
0.34
MutPred
0.50
Gain of phosphorylation at R2580 (P = 0.0202)
MVP
0.76
MPC
0.14
ClinPred
0.038
T
GERP RS
2.1
Varity_R
0.17
gMVP
0.57
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199915459; hg19: chr11-108202716; COSMIC: COSV109415513; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.